Purpose:Humanmetapneumovirus(hMPV)isknowntoresultinclinicalmanifestationsimilartorespiratorysyncytialvirus(RSV)in
RSV군의 세기관지염 환자 중에서는 생후 6개월 미만의 환자가 7/15명(46.7%)으로 상대적으로 많았다 (Fig. 3) . Values are presented as number (%). hMPV, human metapneumovirus; RSV, respiratory syncytial virus.
Fig. 3. Distribution of clinical diagnosis. This shows that there was no significant
difference of respiratory diagnosis between human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) and they induced lower respiratory tract infection mainly. This also shows priority of RSV bronchiolitis at less than 6 months and hMPV pneumonia at more than 25 months. URI, upper respiratory infection . and that between patients infected with hMPV and RSV having bronchiolitis. This suggests that if there were difference of bronchiolitis incidence between two group, it could be explained not by properties of virus infection itself but by commonly involved age. Fig. 5 . Comparison of bronchiolitis incidence in patients infected with human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) at each age subgroup. This shows no significant difference of bronchiolitis incidence between hMPV and RSV at each age subgroup. Test for trend statistics shows bronchiolitis incidence decreased with increased age in both hMPV and RSV group (P<0.05). 
